ADC Synthesis in Flow

Video   May 18, 2016

 

About the Speaker
Graham B. Jones is Professor and Chair of Chemistry & Chemical Biology at Northeastern University in Boston, MA. He also serves as director of translational research for the Tufts Medical Center Clinical and Translational Science Institute. Jones was educated in the UK, receiving BSc (1986) and PhD (1989) degrees in chemistry from the University of Liverpool and the Imperial College of Science Technology and Medicine respectively. He then moved to Harvard University as a NATO fellow to work with E. J. Corey, the 1990 Nobelist. His research program is focused on the development of experimental therapeutics and has resulted in over 140 publications and generated in excess of $30M external funding. Examples include development of antibody-toxin conjugates, treatments for polyglutamine disorders, tissue activated image contrast agents, and cancer immunotherapies. He has been appointed to several editorial posts for scientific journals and is the recipient of numerous awards including the Leblanc Medal, the Leverhulme Prize, the CEM Technology Innovation Award and a DSc degree. Jones gave invited testimony at the 2010 congressional hearings on biopharmaceuticals, and serves as scientific advisor to a number of research foundations and corporations in the USA and UK.
AbstractThe use of continuous flow technology for the synthesis of protein bioconjugates will be presented. In addition to reagent proteins, monoclonal antibody conjugates will also be highlighted.

 
 
 
 

Recommended Videos

Blood, Rats and Anticoagulants: The Story of Warfarin

Video

The history of warfarin, one of the earliest anticoagulant drugs, is littered with the bodies of sick cows and poisoned rats. This animation tells the story of how a bloody beginning gave rise to a life-saving medication.

WATCH NOW

Introduction to Peptides and Proteins for Bioanalysis Using LC-MS

Video

Khalid Khan, Senior Manager Business Development, discusses the basic structure of amino acids, peptides, and proteins, including specific examples like monoclonal antibodies. The ionization and fragmentation of peptides and how they differ from small molecules is also discussed.

WATCH NOW

Solutions for High-Throughput and Phenotypic Screening

Video

Accelerate drug discovery workflows with state-of-the art imaging and detection instruments, assay technologies, reagents, versatile automation systems, and powerful informatics solutions that work together to ensure consistent, accurate, physiologically relevant results. Wrest more meaning from your findings with PerkinElmer's one-of-a-kind analytics, and amplify your phenotypic or target-based screens to identify hits and lead compounds in small and focused or high-throughput volumes.

WATCH NOW

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE